bosentan
Ligand Summary
a specific and competitive antagonist at endothelin receptor types ETA and ETB, has a slightly higher affinity for ETA receptors than for ETB receptors, indicated for the treatment of pulmonary arterial hypertension
UNII: XUL93R30K2
PubChem: 104865
PubChem: 44387533
Guide to Pharmacology: 3494
ChEMBL: CHEMBL957
ChEMBL: CHEMBL175616
DrugCentral: 392
LyCHI: 1YVKQVNNVWAJ
Target Activities
20 Activities
Items per page:
1 – 10 of 20
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
- | ||||||
Ki | ||||||
- | ||||||
Ki | ||||||
IC50 | ||||||
IC50 | ||||||
Ki | ||||||
IC50 | ||||||
Ki | ||||||
IC50 | ||||||